1.The association of TGF?2 polymorphisms and maternal smoking with occurrence of nonsyndromic cleft lip and palate
Guangxiang ZANG ; Yabing MU ; Hongchen SUN ; Lifan FENG ; Zebing ZHANG
Journal of Practical Stomatology 2000;0(06):-
Objective:To study the association of TGF?2 polymorphisms and maternal smoking with the occurrence of nonsyndromic cleft lip and palate(NSCLP). Methods:TGF?2 genes were amplified from peripheral leukocytes by means of PCR in 272 cases of nonsyndromic cleft lip with or without palate(CL/P), 251 of cleft palate only(CPO) and 312 of unrelated controls in Jilin Province, PCR products were analyzed by single-stranded conformation polymorphism(SSCP) and DNA sequencing. Maternal smoking was investigated. The association of TGF?2 polymorphisms, maternal smoking with the occurrence of CL/P and CPO was analyzed by SAS statistic system. Results:The 322 bp PCR product of TGF?2 was amplified from CL/P, CPO and control samples; SSCP analysis showed three alleles of TGF?2;sequencing results showed that allele1, allele2 and allele3 contained seven, eight and nine ACA repeats respectively. The statistic analysis showed that TGF?2 polymorphisms or maternal smoking was associated with the occurrence of CL/P and CPO respectively(P0.05).Conclusion:TGF?2 polymorphisms and maternal smoking during pregnancy are associated with the occurrence of CL/P and CPO. TGF?2 polymorphisms have no interaction with maternal smoking.
2.Fiber choledochoscope in treatment of patients with biliary cast syndrome after liver transplantation
Jing YANG ; Tao LIU ; Lin SUN ; Guangxiang JIA ; Yunjin ZANG ; Xiao HU
Chinese Journal of Hepatic Surgery(Electronic Edition) 2018;7(3):202-205
Objective To investigate the safety and efficacy of fiber choledochoscope in the treatment of patients with biliary cast syndrome (BCS) after liver transplantation (LT).Methods Clinical data of 10 patients with BCS after LT treated with fiber choledochoscope in the Affiliated Hospital of Qingdao University between March 2014 and June 2016 were analyzed retrospectively. There were 8 males and 2 females, aged 46-66 years old and the median age was 50 years old. The primary diseases of the patients were primary liver cancer (n=6), biliary cirrhosis (n=1), hepatic cirrhosis after hepatitis B (n=2), and hepatic cirrhosis after hepatitis C (n=1). The informed consents of all patients were obtained and the local ethical committee approval was received. For patients with BCS in the early stage after LT, T tube was replaced. For patients in late stage after LT, T tube fistula dilatation was performed, then biliary cast (BC) was removed and the supporting drainage tube was placed.Results 2 cases received T tube replacement when in early stage after LT, 8 received T tube fistula dilatation when in late stage after LT. All 10 cases had BC removed successfully with fiber choledochoscope. Liver function of 8 cases returned to normal after surgery, and the biliary drainage tube was removed. 2 cases had BC again and recurrent biliary infection, and then received PTCD drainage. Conclusion Fiber choledochoscope is safe, effective and feasible for the treatment of BCS after LT.